Abstract
The reticuloendothelial system (RES) consists of a network of sessile and mobile mononuclear phagocytes which perform a variety of physiological functions with respect to host defense. Those fixed macrophages that reside in the liver and spleen and comprise the majority of the RES are uniquely located anatomically such that they can monitor the circulation and have been demonstrated to remove a variety of blood-borne toxic and particulate material of both endogenous and exogenous origin (37). These cells can selectively recognize and remove from the vascular compartment endogenously generated material including cell debris (26), denatured collagen (43), fibrin aggregates (23), and a variety of exogenous colloidal and particulate material including bacteria (4,16,34,41). Early studies involved in the evaluation of the activity of this system which is responsible for the removal of circulating particulate demonstrated that activation of the system as evidenced by an enhanced rate of removal of test particulate from the blood was associated with an increased resistance to a variety of pathophysiological situations such as traumatic injury (51), infection (34), and tumor growth (4). Conversely, depression of the clearance capacity of the system resulted in an increased sensitivity of experimental animals to the same pathological insults. Therefore, the concept that the RES was important in host defense processes became firmly established.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allen, C., Saba, T.M., Molnar, J.: Isolation, purification and characterization of opsonic protein. J. Reticuloendothelial Soc. 13: 410, 1973.
Annest, S.J., Scovill, W.A., Blumenstock, F.A., Stratton, H.H., Newell, J.C., Paloski, W.H., Saba, T.M., Powers, S.R.: Increased creatinine clearance following cryoprecipitate infusion in trauma and surgical patients with decreased renal function. J. Trauma 20: 726, 1980.
Atherton, B.T., Hynes, R.O.: A difference between plasma and cellular fibronectins located with monoclonal antibodies. Cell 25: 133 1981.
Biozzi, B., Stiffel, C., Halpern, B.M., Manton, D.: Etude de la fonction phagocytaire du SRE au cours du développement de tumeurs expérimentales chez le rat et la souris. Ann. Inst. Pasteur. 94: 681, 1958.
Biozzi, G., Benacerraf, B., Halpern, B.N.: Quantitative study of the granulopectic activity of the reticuloendothelial system. II. A study of the kinetics of the granulopectic activity of the RES in relation to the dose of carbon injected. Relationship between the weight of the organs and their activity. Brit. J. Exp. Path. 34: 441, 1953.
Blumenstock, F.A., Saha, T.M.: Purification of alpha-2-opsonic glycoprotein from human serum and its measurement by immunoassay. J. Reticuloendothelial Soc. 23: 119, 1978.
Blumenstock, F.A., Saba, T.M., Weber, P., Cho, E.: Purification and biochemical characterization of a macrophage stimulated alpha2-globulin opsonic protein. J. Reticuloendothelial Soc. 19: 157, 1976.
Blumenstock, F.A., Saba, T.M., Weber, P., Laffin, R.: Biochemical and immunological characterization of human opsonic alpha-2-SB glycoprotein; Its identity with cold-insoluble globulin. J. Biol. Chem. 253: 4387, 1978.
Blumenstock, F.A., Weber, P.B., Saba, T.M.: Isolation and purification from rat serum of an alpha-2-opsonic glycoprotein. J. Biol. Chem. 252: 7156, 1977.
Blumenstock, F.A., Weber, P., Saba, T.M., Laffin, R.: Electroimmunoassay of alpha-2-opsonic protein during reticuloendothelial blockade. Am. J. Physiol. 232: R80, 1977.
Brodin, B., Bergham, L., Frigerg-Nielson, S., Nordstrom, H., Schildt, B.: Fibronectin in the treatment of septicemia - a preliminary report. Excerpta Medica. 7th World Congress of Anesthesiology. Hamburg, 1980, p. 504.
Dillon, B.C., Saba, T.M.: Starvation-induced hepatic phagocytic depression: Role of opsonic fibronectin and neutrophils in the distribution of blood-borne taphcloeoceus aureur. Abstracts of Association for Academic Surgery, 1981, p. 68.
Dillon, B.C., Saba, T.M., Cho, E., Lewis, E.: Opsonic fibronectin deficiency in the etiology of starvation induced reticuloendothelial phagocytic dysfunction. Exp. and Molec. Path. 36 (in press), 1982.
Di Luzio, N.R.: Macrophages, recognition factors and neoplasia. In: RES System. International Academy of Pathology Monograph. Baltimore, MD, Williams and Wilkins, 1975, p. 49.
Engel, J., Odermatt, E., Engel, A., Madri, J.A., Furthmayer, H., Rohde, H., Timpl, R.: Shapes, domain organization and flexibility of laminin in fibronectin. Two multi-functional proteins of the extracellular matrix. J. Molec. Biol. 150: 97, 1981.
Filkins, F.P.: Detoxification of endotoxin by leukocytes and macrophages. Proc. Soc. Exp. Biol. Med. 137: 1396, 1971.
Filkins, F.P., Chase, R.E., Smith, J.J.: Characteristics of a plasma factor governing carbon phagocytosis in the isolated per-fused rat liver. J. Reticuloendothelial Soc. 2: 287, 1965.
Graham, C.W., Blumenstock, F.A., Saha, T.M., Gotoff, S.: Labor modulates alpha-2-opsonic protein (2OP) for fixed macrophages. J. Reticuloendothelial Soc. 24: 31a, 1978.
Graham, C.W., Saba, T.M.: Opsonin in reticuloendothelial regulation during and following pregnancy. J. Reticuloendothelial Soc. 14: 121, 1973.
Jilek, F., Hormann, H.: Fibronectin (cold-insoluble globulin). VI. Influence of heparin and hyaluronic acid on the binding of native collagen. Hoppe-Seyler’s Z. Physiol. Chem. 360: 597, 1979.
Kaplan, J.E., Saba, T.M.: Humoral deficiency and reticuloendothelial depression after traumatic shock. Am. J. Physiol. 230: 7, 1976
Kaplan, J.E., Saba, T.M., Cho, E.: Serological modifications of reticuloendothelial capacity and altered resistance to traumatic shock. Circ. Shock 3: 203, 1976.
Kaplan, J.E.: The role of the reticuloendothelial system in control of hemostatic and thrombotic mechanisms. In: Pathophysiology of the Reticuloendothelial System. eds. B.M. Altura and T.M. Saba. Raven Press, New York, 1981, p. 111.
Lanser, M.E., Saba, T.M., Scovill, W.A.: Opsonic glycoprotein (plasma fibronectin) levels after burn injury: Relationship to extent of burn and development of
Manwaring, W.H., Coe, H.C.: Endothelial opsonins. J. Immunol. 1: 401, 1916.
Molnar, J., McLain, S., Allen, C., Laga, H., Gava, A., Gelder, R.: Specificity of a non-complement related opsonic protein. Biochem. Biophys. Acta 493: 37, 1977.
Morrison, P.R., Edsall, J.T., Miller, S.G.: Preparation and properties of serum and plasma proteins. XVIII. The separation of purified fibrinogen from fraction I of human plasma. J. Am. Chem. Soc. 70: 3103, 1948.
Mosesson, M.W., Umfleet, R.A.: The cold-insoluble globulin of human plasma. I. Purification, primary characterization and relationship to fibrinogen and other cold-insoluble fraction components. J. Biol. Chem. 245: 572 8, 1970.
Mosher, D.F.: Changes in plasma cold-insoluble globulin concentration during experimental Rocky Mountain Spotted Fever infection in rhesus monkeys. Thromb. Res. 9: 37, 1976.
Mosher, D.F.: Cross-linking of cold-insoluble globulin by fibrin stabilizing factors. J. Biol. Chem. 250: 6614, 1976.
Mosher, D.F., Williams, E.M.: Fibronectin concentration is decreased in plasma of severely ill patients with disseminated intra-vascular coagulation. J. Lab. Clin. Med. 91: 729, 1978.
Ruoslahti, E., Vaheri, A.: Interaction of soluble fibroblast surface antigens with fibrinogen and fibrin. Identity with cold-insoluble globulin of human plasma. J. Exp. Med. 141: 497, 1975.
Robbins, A.B., Doran, J.E., Reese, A.C., Mansberger, A.R.: Cold-insoluble globulin levels in operative trauma: Serum depletion, wound sequestration and biological activity. Am. Surg. 46: 663, 1980.
Rogers, B.E.: Host mechanisms which act to remove bacteria from the bloodstream. Bart. Rev. 24: 50, 1960.
Saba, T.M.: Physiology and pathophysiology of the reticuloendothelial system. Arch. Intern. Med. 126: 1031, 1970.
Saba, T.M.: Aspecific Opsonins. In: Proc. of 4th Internat. Convocation on immunology. In: Immune System and Infectious Diseases. S. Karger Co., Basel, 1975, p. 489.
Saba, T.M., Antikatzides, T.G.: Humoral mediated macrophage response during tumor growth. Brit. J. Cancer 21: 471, 1975.
Saba, T.M., Albert, W.H., Blumenstock, F.A., Evanega, G., Staehler, F., Cho, F.: Evaluation of a rapid immunoturbidimetric assay for opsonic fibronectin in surgical and trauma patients administered cryoprecipitate. J. Lab. Clin. Med. 90: 473, 1981.
Saba, T.M., Blumenstock, F.A., Scovill, W.A., Bernard, H.R.: Cryoprecipitate reversal of opsonic alpha-2-surface binding glycoprotein deficiency in septic surgical and trauma patients. Science 201:622., 1977.
Saba, T.M., Blumenstock, F.A., Weber, P., Kaplan, J.E.: Physiologic role for cold-insoluble globulin in systemic host defense: Implications of its characterization as the opsonic R2SB glycoprotein. Ann. N.Y. Acad. Sci. 312: 43, 1978.
Saba, T.M., Di Luzio, N.R.: Kupffer cell phagocytosis and metabolism of a variety of particles as a function of opsonization. J. Reticuloendothelial Soc. 2: 437, 1965.
Saba, T.M., Di Luzi_o, N.R.: Reticuloendothelial blockade and recovery as a function of opsonic activity. Am. J. Physiol. 216: 197, 1969.
Saba, T.M., Jaffe, E.: Plasma fibronectin (opsonic glycoprotein): Its synthesis by vascular endothelial cells and role in cardiopulmonary integrity after trauma as related to reticuloendothelial function. Am. J. Med. 68: 577, 1980.
Scovill, W.A., Saba, T.M., Blumenstock, F.A., Bernard, H., Powers, S.R.: Opsonic alpha-2-surface binding glycoprotein therapy during sepsis. Ann. Surg. 188: 521, 1978.
Scovill, W.A., Saba, T.M., Kaplan, J.E., Bernard, H.R., Powers, S.R.: Disturbances in circulating opsonic activity in man after operative and blunt trauma. J. Surg. Res. 22: 709, 1977.
Snyder, E.L., Mosher, D.F., Hezzey, A., Golenwski, G.: Effect of blood transfusion on in vivo levels of plasma fibronectin. J. Lab. Clin. Med. 98: 336, 1981.
Stathakis, N.E., Fountas, A., Tsianos, E.: Plasma fibronectin in normal subjects and in various disease states. J. Clin. Pathol. 34: 504, 1981.
Stossel, T.P.: Phagocytosis. New Engl. J. Med. 290: 717, 1974.
Yamada, K.M., Kennedy, D.W.: Fibroblast cellular and plasma fibronectin are similar but not identical. J. Cell. Biol. 80: 492, 1979
Yamada, K.M., Olden, K.: Fibronectin: Adhesive glycoproteins of cell surface and blood. Nature 275: 179, 1978.
Zweifach, B.W. Benacerraf, B., Thomas, L.: Relationship between the vascular manifestation of shock produced by endotoxin, trauma and hemorrhage. II. The possible role of the RES in resistance to each type of shock. J. Exp. Med. 106: 403, 1957.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Martinus Nijhoff Publishers, The Hague
About this chapter
Cite this chapter
Blumenstock, F.A., Saba, T.M., Kaplan, J.E. (1982). Plasma Fibronectin: Biochemical Properties and Clinical Relevance. In: Smit Sibinga, C.T., Das, P.C., van Loghem, J.J. (eds) Bloodtransfusion and Problems of Bleeding. Developments in Hematology and Immunology, vol 5. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-7692-4_10
Download citation
DOI: https://doi.org/10.1007/978-94-009-7692-4_10
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-7694-8
Online ISBN: 978-94-009-7692-4
eBook Packages: Springer Book Archive